CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Loomis David K VP, Chief Accounting Officer | Sale 10b5-1 | −232 | $6.36 | $1K | 39,961 |
| 2026-06-24 | Smaldone Alsup Laurie Director | Grant or award | +15,527 | 41,572 | ||
| 2026-06-24 | Smaldone Alsup Laurie Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Norwalk Leslie V Director | Grant or award | +15,527 | 41,572 | ||
| 2026-06-24 | Norwalk Leslie V Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Morrison Briggs Director | Grant or award | +15,527 | 111,548 | ||
| 2026-06-24 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Kennedy Edward Moore Jr. Director | Grant or award | +15,527 | 54,957 | ||
| 2026-06-24 | Kennedy Edward Moore Jr. Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Cunningham Everett Director | Grant or award | +15,527 | 41,572 | ||
| 2026-06-24 | Cunningham Everett Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Bain Linda Director | Grant or award | +15,527 | 41,572 | ||
| 2026-06-24 | Bain Linda Director | Grant or award · Stock Option (right to buy) | +22,714 | 22,714 | ||
| 2026-06-24 | Saik Andrew Chief Financial Officer | Sale 10b5-1 | −5,696 | $8.16 | $46K | 187,432 |
| 2026-06-17 | Cacace Angela M Chief Scientific Officer | Sale 10b5-1 | −2,576 | $7.60 | $20K | 180,390 |
| 2026-05-21 | Teel Randy President and CEO | Sale | −2,209 | $9.04 | $20K | 285,009 |
| 2026-05-11 | Saik Andrew Chief Financial Officer | Sale | −11,139 | $9.94 | $111K | 193,128 |
| 2026-05-11 | Loomis David K VP, Chief Accounting Officer | Sale | −1,919 | $9.94 | $19K | 40,193 |
| 2026-05-11 | Cacace Angela M Chief Scientific Officer | Sale | −9,657 | $9.94 | $96K | 182,966 |
| 2026-05-11 | Berkowitz Noah Chief Medical Officer | Sale | −11,108 | $9.94 | $110K | 191,395 |
Page 1 of 10 · 184 trades